Ulanqab Kema’s growth is underpinned by a multifaceted strategic advantage. Its location in Ulanqab, Inner Mongolia, provides ...
In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...
How Ropack’s evolution from service provider to strategic CMO partner reflects broader shifts in manufacturing, packaging, ...
With the FDA tightening its guidance around the production of nonbacterial beta-lactam drugs, Swedish CDMO Recipharm is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results